. Introduction
the mechanisms that play a role in the interaction between inflammation and coagulation will be reviewed and speThe relevance of the interaction between coagulation cific features of infectious disease-mediated effects on the and inflammation as a response to severe infection, in its coagulation system will be highlighted. In addition, the most extreme form manifesting as disseminated intravascucross-talk between activated coagulation and inflammatory lar coagulation (DIC) and multiple organ failure, is mediators will be discussed. becoming increasingly clear [1, 2] . In recent years, the various mechanisms that play an important role in this interaction have been elucidated and this knowledge has 2 . Inflammation-induced coagulation modification indeed been demonstrated to be applicable for the improvement of our understanding of the pathogenesis of It has long been known that inflammation can lead to severe infection or sepsis and, even more importantly, the activation of the coagulation system. Acute inflammation, clinical management of these patients [3] . In this article, as a response to severe infection or trauma, results in a systemic activation of the coagulation system [3, 4] . It was initially thought that this systemic activation of coagulation was a result of direct activation of the contact system of coagulation by microorganisms or endotoxin. However, in 3 . Mechanisms of inflammation-induced coagulation the 1990s, it became apparent that cytokines played a and fibrinolysis activation mediatory role in the activation of coagulation and subsequent fibrin deposition and that the point of impact on Inflammation-induced coagulation activation is charthe coagulation system was rather the tissue factor-factor acterized by widespread intravascular fibrin deposition, VIIa ('extrinsic') pathway than the contact system ('intrinwhich appears to be a result of enhanced fibrin formation sic pathway') [5, 6] . Furthermore, the significance of and impaired fibrin degradation [1, 11] . As outlined in the impaired physiological anticoagulant pathways became following paragraphs and schematically represented in Fig.  increasingly clear [7] . Lastly, it was shown that impaired 1, enhanced fibrin formation is caused by tissue factorfibrin removal by a suppressed fibrinolytic system conmediated thrombin generation and simultaneously occurtributed importantly to the microvascular deposition of ring depression of inhibitory mechanisms, such as the fibrin.
protein C and S system. The impairment of endogenous Vascular endothelial cells play a central role in all thrombolysis is mainly due to high circulating levels of mechanisms that contribute to inflammation-induced acti-PAI-1, the principal inhibitor of plasminogen activation. vation of coagulation. Endothelial cells respond to the These derangements in coagulation and fibrinolysis are cytokines expressed and released by activated leukocytes mediated by differential effects of various pro-inflammabut can also release cytokines themselves [8] . Furthermore, tory cytokines [5] . endothelial cells are able to express adhesion molecules and growth factors that may not only promote the in-3 .1. Tissue factor flammatory response further but also affect the coagulation response ( Fig. 1) . However, it has recently become clear
The initiating factors comprise the molecule tissue factor that, in addition to these mostly indirect effects of the and the plasma protein factor VII(a) [12] . Tissue factor is a endothelium, endothelial cells interfere directly with the membrane-bound 4.5-kDa protein, which is constitutively initiation and regulation of fibrin formation and removal expressed on a number of cells throughout the body [13] . during severe infection [9, 10] .
These cells are mostly in tissues not in direct contact with blood, such as the adventitial layer of larger blood vessels. and vascular beds, but it is uncertain whether its expression The subcutaneous tissue also contains substantial amounts is genetically controlled in an organ specific way [9] . of TF, and histologically TF appears to be present in all blood tissue barriers [14] . Upon expression at the cell 3 .2. The contact system surface, TF can interact with factor VII, either in its zymogen or activated form [15] . Upon complexing, factor Whether in humans with severe infection the contact VII is activated, and the TF-factor VIIa complex catalyzes route plays any role remains unknown. Negatively charged the conversion of both factors IX and X [16, 17] . Factors substances including phospholipids and glycosaminoglyIXa and Xa enhance the activation of factors X and cans, are a theoretically relevant source of contact activaprothrombin, respectively (Fig. 1) . In cells in contact with tion. Recent studies suggest that intact cell surfaces the blood circulation, TF is induced by the action of mediate the assembly of contact factor proteins that may several compounds including cytokines, C reactive protein initiate this route of activation [25] . The assembly of and advanced glycosilated endproducts [14] . Inducible TF kininogens on a multiprotein receptor leads to controlled is predominantly expressed by monocytes and macroprekallikein activation. In the case of endothelial cells a phages. The expression of TF on monocytes is markedly complex between high molecular weight kininogen (HK) stimulated by the presence of platelets and granulocytes in and prekallikrein or factor XI binds to a multiprotein a P-selectin dependent reaction [18] . This effect may be receptor on these cells. This receptor consists of cytothe result of nuclear factor kappa B (NFkB) activation keratin 1, uPAR and gC1qR [25] . Cytokeratin 1 was also induced by binding of activated platelets to neutrophils and demonstrated on platelets and granulocytes, which may mononuclear cells. This cellular interaction also markedly allow the interaction of HK with these cells as well. On enhances the production of IL-1b, IL-8, MCP-1, and TNFa endothelial cells, PK activation leads to factor XII conver- [19] .
sion amplifying PK activation. The activation of PK causes Under in vitro conditions, different cytokines such as the cleavage of HK and liberation of bradykinin. Bradytumor necrosis factor a (TNFa), and interleukin (IL) 1, kinin induces tPA and this is one of the potential direct induce TF by vascular endothelial cells, but its relevance effects of the contact system on fibrinolysis [26, 27, 27] . for in vivo coagulation is uncertain [14, 20] . TF has also Several lines of evidence support the important role of the been localized on polymorphonuclear cells (PMN) in contact system in activating fibrinolysis. Additional studies whole blood and ex vivo perfusion systems, suggesting an indicate that kininogens contain a peptide fragment that additional pool of 'blood borne' TF [21] , but it is unlikely interferes with thrombin binding to platelets through that PMN actually synthesize TF in detectable quantities preventing peptide liberation from PAR1 by thrombin [28] . [22] . Finally, TF and associated procoagulant activity in Taken together, a profibrinolytic and anticoagulant funcvitro has been detected on microvesicles derived from tion of the contact system is more likely than a procoagulpredominantly platelets and granulocytes in patients with ant role in vivo. meningococcal sepsis [23] . The localization on microvesiStudies in patients with a clinical suspicion of DIC cles may imply a highly efficient pool of procoagulant showed elevated levels of markers of activation of the material assembling not only the initiating TF-factor VIIa contact system. Kaufmann et al. measured elevated concomplex but also the phospholipid surface facilitating the centrations of kininogen-a 1 anti-trypsin complexes [29] , development of the tenase and prothrombinase complexes.
however studies with similar methods for coagulation In addition, a soluble form of TF is detectable in plasma activation markers have hardly ever detected elevated from humans, and its levels are elevated in DIC [24] . The levels of contact activation [30] . A study in patients with significance of soluble TF is unknown. It is likely the meningococcal septicemia showed a negative correlation result of membrane cleavage by metalloproteinases probetween plasma factor XII levels and factor XIIa-C1 duced under inflammatory conditions, and it circulates in inhibitor complexes [31] . Although this would suggest free as well as complexed forms. Whether soluble TF is consumption of factor XII, and subsequent activation of catalytically active and involved in inducing coagulation factor XI downstream, a possible alternative explanation is remains to be investigated. In addition to its effect on the a negative acute phase effect with reduced synthesis of haemostatic system, tissue factor also has cell signalling factor XII, in conjunction with thrombin-mediated activaand mitogenic effects. These effects are probably mediated tion of factor XI [32] . by the protease-activated receptors (PARs) 1 and 2. Other Experimental studies suggested that blockade of the examples of such effects are described below in the contact route in an E. coli sepsis model in primates with a paragraph describing the cross-talk between coagulation monoclonal antibody against factor XIIa failed to protect and inflammation.
animals from the coagulation derangement, but diminished In humans with infection and an activated coagulation development of lethal hypotension [33] . This latter study system, monocytes expressing enhanced levels of TF and provided reasonable support for the current view that the procoagulant activity have been demonstrated. The tissue contact activation pathway does not contribute to coagulaexpression of TF appears to be confined to certain organs tion activation. The contact route may play important roles in pro-inflammatory mechanisms related to vascular perpreparation reduced the severity of DIC, but did not protect meability, vascular proliferative processes (role of the animals from dying due to sepsis [43] . The protective kininogen in smooth muscle cell proliferation) and stimulaeffect of antithrombin may have resulted from an antition of fibrinolysis [34] .
inflammatory effect. Infusion of recombinant antithrombin at very high concentrations (about 10-fold higher than the 3 .3. Physiological anticoagulant pathways basal plasma concentration) markedly reduced mortality due to lethal E. coli infusion, but also caused a significant Systemic activation of coagulation upon inflammation is reduction in the plasma levels of IL-6 and IL-8 [44] . In counteracted by several mechanisms. First, coagulation spite of significantly higher levels of TNFa and lower inhibitors are present to slow down the coagulation levels of IL-10, the overall effect on DIC was apparently mechanism (Fig. 2) . Soluble inhibitors constitute antifavourable because the reduction in fibrinogen level was thrombin (AT), proteins C and S, and tissue factor pathway less pronounced in the AT-treated animals. An unexpected inhibitor (TFPI) [35] . Antithrombin inhibits coagulation finding was that tPA levels, after an initial small rise in proteases by 1:1 complex formation, which, in the case of both groups, were markedly lower in the E. coli challenged thrombin-antithrombin complexes, can be detected by baboons given antithrombin. As a result there was no immunoassay in plasma from patients with DIC [24, 36] .
increment in the levels of plasmin-antiplasmin complexes AT is thought to be one of the most important inhibitors of (PAP), whereas the increase in PAI-1 levels was somewhat the activated coagulation system, and markedly lowered increased in AT-treated animals. plasma levels are found in sepsis [37, 38] . In the course of Since TNFa is a critical mediator of fibrinolysis in DIC the function of AT may be influenced in several ways.
primates given a low-dose endotoxin [45] , and given the First, a reduced absolute amount of the inhibitor may occur elevated levels of TNF-a in baboons given antithrombin, a due to reduced protein synthesis on the one hand and marked increase in tPA and PAP complexes would have clearance on the other hand. Clearance may be either in the been expected in the baboon model after AT infusion. The form of protease-inhibitor complex, or due to proteolytic absence thereof suggests that TNF-a is not the single most cleavage by proteolytic enzymes including granulocyte important cytokine influencing fibrinolysis in sepsis. Poelastase [39] . Second, the function of AT may be impaired tentially, the rise of PAI-1 sufficiently blunts fibrinolysis, due to the possibly reduced availability of glycosaminobut an alternative explanation may be a direct effect of glycans which may act as the physiological heparin-like antithrombin at tPA release by the endothelium, caused by cofactor of AT [40] . Under the influence of cytokines the AT binding to glycosaminoglycans at the endothelial synthesis of glycosaminoglycans by endothelial cells may surface. Given the net negative effect on fibrinolysis, the be reduced, impairing the inhibitory potential of AT [41] .
incomplete protection only achieved at very high doses of In animal models of experimental bacteremia, an antiantithrombin, the therapeutic potential of antithrombin may thrombin concentrate prolonged survival and reduced the be limited. severity of DIC [42] . This protective effect may have been Protein C and its cofactor protein S form a second line distinct from the anticoagulant effect as such because in of defense. Thrombin binds to the endothelial cell memone of these models, an active site blocked factor Xa brane associated molecule thrombomodulin, and this com- Fig. 2 . Point of impact of the three major physiological anticoagulant pathways. Antithrombin is the most important inhibitor of thrombin and factor Xa, activated protein C is able to degrade the essential cofactors Va and VIIIa, and TFPI inhibits the tissue factor / factor VIIa complex. Abbreviation: TFPI, tissue factor pathway inhibitor.
in the E. coli baboon model [56] . Vice versa, infusion of PC in the same model, protected against DIC and dying [57] . Thus, it appears that the protein C mechanism is of great importance in the host defense against sepsis and coagulation activation. In situations, associated with DIC and systemic inflammation, TNFa and interleukin-1 may significantly down-regulate the cellular expression of thrombomodulin, as suggested by cell culture experiments [58] [59] [60] . The formation of thrombin may induce the shedding of EPCR by the endothelium, due to activation of metalloproteinases by thrombin. It is presently unknown whether thrombomodulin is also cleaved by similar mechanisms.
A third inhibitory mechanism constitutes TFPI. This molecule, which exists in several pools either endothelial cell associated, or lipoprotein bound in plasma, inhibits the TF-factor VIIa complex by forming a quaternary complex in which factor Xa is the fourth component [61] . Clinical coagulation (DIC) is due to low levels of zymogen protein C, downregustudies in septic patients have not provided clues as to its lation of thrombomodulin and the endothelial protein C receptor and low importance, because in the majority of patients the levels levels of free protein S due to acute phase-induced high levels of its of TFPI are not diminished compared to normals [62] . This binding protein (i.e. C4b-binding protein).
may be explained by the lack of downregulatory effects of inflammatory mediators on cultured endothelial cells [63] . The relevance of TFPI in sepsis-induced coagulation plex converts protein C to its active form, protein Ca (PCa) activation is illustrated by two lines of experimentation. (Fig. 3) [46]. In addition, the thrombin-thrombomodulin First, depletion of TFPI sensitized rabbits to DIC induced complex accelerates the conversion of the thrombin acwith tissue factor infusion sensitizes the animals to develop tivatable fibrinolytic inhibitor (TAFI) [47] . PCa inactivates a more severe DIC [64] . Second, TFPI infusion protected factors Va and VIIIa by proteolytic cleavage, thus slowing against the harmful effects of E. coli in primates. In this down the coagulation cascade. Endothelial cells, primarily study, TFPI not only blocked DIC but all baboons chalof large blood vessels, express an endothelial protein C lenged with lethal amounts of E. coli showed a marked receptor (EPCR), which augments the activation of protein improvement in vital functions and survived the experi-C at the cell surface [48] [49] [50] . Activated protein C has ment without apparent complications [65] . The beneficial anti-inflammatory effects on mononuclear cells and graneffects of TFPI may in part be due to its capacity to bind ulocytes, which may be distinct from its anticoagulant endotoxin and to interfere with its interaction with CD14 activity. Administration of PCa prevented thrombin-in- [66] , and to its attenuating effect on IL-6 generation. A duced thromboembolism in mice, mainly through its recent study in volunteers confirmed the potential of TFPI antithrombotic effect [51] . An anti-inflammatory effect of to block the procoagulant pathway triggered by endotoxin PCa was demonstrated by Hancock et al. [52] , showing [67] . However, in this study in healthy subjects, there was reduced TNFa production in rats challenged with endotoxno reduction in cytokine levels, in contrast to the apparent in. Activated PC reduced the severity of spinal cord injury anti-inflammatory effect of TFPI in the baboon study. in rats, probably due to inhibition of leukocyte activity There are several possible explanations for this dis- [53] . In the latter model, soluble thrombomodulin had a crepancy, which all relate to the marked differences similar anti-inflammatory effect, but this was also mebetween the endotoxin and E. coli sepsis models in which diated by PCa. In a pulmonary inflammatory model the effects of TFPI were investigated. In the beneficial induced by endotoxin, thrombomodulin also reduced vaseffects of TFPI on survival, anti-inflammatory effects cular permeability through a protein C-dependent mecharather than antithrombotic activity may be prominent [65] . nism [54] .
In general, the presence of intact function and normal In contrast, defects in the protein C mechanism enhance plasma levels of inhibitors appears to be important in the the vulnerability to inflammatory reactions and the ensuing defense against DIC. It should be noted however, that there activation of coagulation. In patient studies, lowered levels are no strong indications that individuals with congenital of protein C and protein S are associated with increased deficiencies of inhibitors would suffer a greater chance of mortality. Blockade of the activity of protein C by infusion developing DIC, but this issue remains to be explored. In of C4 binding protein turns a sublethal model of E. coli in addition, the influence of inhibitors in modifying the baboons into a lethal model [55] . Blockade of EPCR by a interaction between coagulation and inflammation deserves neutralizing monoclonal antibody also increased mortality further attention.
.4.
Fibrinolysis release PAI-1 upon their activation. Since platelets become activated in case of severe inflammation and infection, this In experimental models of severe infection, fibrinolysis may further increase the levels of PAI-1 and contribute to is activated, demonstrated by an initial activation of the fibrinolytic shut-off. plasminogen activation, followed by a marked impairment caused by the release in blood of plasminogen activator 3 .5. Platelets inhibitor, type 1 (PAI-1) [45, 68, 69] . The latter inhibitor strongly inhibits fibrinolysis causing a net procoagulant
In addition to the mechanisms described above, platelets situation. The molecular basis is cytokine-mediated activamay play a role in the pathogenesis of inflammationtion of vascular endothelial cells; TNFa and IL-1 deinduced coagulation activation as well. Endotoxin can creased free tPA and increased PAI-1 production, TNFa directly activate platelets and many pro-inflammatory increased total uPA production in endothelial cells [70, 71] .
cytokines are capable of inducing platelet activation Endotoxin and TNFa stimulated PAI-1 production in liver, through the sphingosine pathway and platelet activating kidney, lung and adrenals of mice. The net procoagulant factor (PAF) and its receptor. The importance of platelet state is illustrated by a late rise in fibrin breakdown activation for the activation of coagulation in severe fragments after E. coli challenge of baboons. Experimental infection is probably related to the provision of a suitable data also indicate that the fibrinolytic mechanism is active phospholipid surface on the activated platelet membrane in clearing fibrin from organs and circulation. Endotoxinfor assembly of complexes of activated coagulation facinduced fibrin formation in kidneys and adrenals was most tors, such as the prothrombinase complex, consisting of dependent on a decrease in urokinase type plasminogen activated factors X and V, prothrombin and calcium. The activator (uPA) [72] . PAI-1 knockout mice challenged with presence of such a surface may catalyze several-fold the endotoxin did not develop thrombi in the kidney in generation of thrombin and render the coagulation system contrast to wild-type animals [71] . Endotoxin administraless susceptible to fluid-phase protease inhibitors. tion to mice with a functionally inactive thrombomodulin gene (TMProArg mutation) and defective protein C activator cofactor function caused fibrin plugs in the pulmon-4 . Cytokines and other mediatory factors ary circulation, while wild-type animals did not develop macroscopic fibrin [73] . This phenomenon proved to be Activation of blood coagulation requires a number of temporary, with detectable thrombi at 4 h after endotoxin, cofactors. In particular, to develop coagulation activation, and disappearance of clots at 24 h in animals sacrificed at a number of interacting surfaces from cell remnants or that timepoint. These experiments demonstrate that fibintact cells, inflammatory mediators and coagulation prorinolytic action is required to reduce the extent of inteins is required. The stimulus is presented by the underlytravascular fibrin formation.
ing disease and can thus be diverse: a bacterial cell Fibrinolytic activity is markedly regulated by PAI-1, the compound such as endotoxin, a protease induced by a principal inhibitor of this system. Recent studies have malignant cell type, tissue damage exposing catalytic shown that a functional mutation in the PAI-1 gene, the surfaces and constitutively expressed TF, a substance that 4G / 5G polymorphism, not only influenced the plasma might directly activate coagulation (fat, amniotic fluid) by levels of PAI-1, but was also linked to clinical outcome of unknown pathways, or others. Each of these triggers meningococcal septicemia. Patients with the 4G / 4G genointeract with other mediators: TF assembles on phostype had significantly higher PAI-1 concentrations in pholipids, cells provide catalytic surfaces by exposure of plasma and an increased risk of death [74] . Further phosphatidyl serine, cytokines interact with receptors and investigations demonstrated that the PAI-1 polymorphism induce signalling pathways that induce TF and other did not influence the risk of contracting meningitis as such, proinflammatory components via the NFkB complex. To but probably increased the likelihood of developing septic illustrate this situation, we will describe in greater detail shock from meningococcal infection [75] . These studies the mechanisms that lead to endotoxin-induced activation are the first evidence that genetically determined differof the coagulation mechanism. This model provides the ences in the level of fibrinolysis influences the risk of best studied model of the complex network of interactions developing complications of a Gram-negative infection. In that involves activated coagulation in a DIC like fashion other clinical studies in cohorts of patients with DIC, high [78] . Endotoxin is the lipopolysaccharide compound from plasma levels of PAI-1 were one of the best predictors of Gram-negative bacteria inducing the sepsis syndrome and mortality [76, 77] . These data suggest that activation of DIC. Gram-negative bacteria liberate endotoxins from their coagulation contributes to mortality in this situation, but as membrane which interact with cell surfaces by different indicated earlier, the fact that PAI-1 is an acute phase pathways. In blood, endotoxin directly binds to CD 14 at protein, a higher plasma concentration may also be a monocytes, and binds to endothelial cells after complexing marker of disease rather than a causal factor. Interestingly, with lipopolysaccharide binding protein (LBP) and the platelet a-granules contain large quantities of PAI-1 and Toll-like receptor 4 complex [79] . By these interactions, endotoxin induces a number of signalling pathways leading the strength of the trigger may determine the degree of to the activation of the NFkB system, which starts the involvement of the cytokine network and its interactions transcription of genes of proinflammatory cytokines, TF with the coagulation system. and others. These mechanisms are further reviewed elseMonocytes expressing TF directly bind factor VII(a), where [80] .
shed TF, or become associated with the damaged vessel Except for a direct positive effect of endotoxin on TF wall, a process probably occurring when macrophages synthesis, the formation of the cytokines IL-1, TNFa, and expressing TF invade the vessel wall and play a procoagul-IL-6 stimulates TF formation [14] . Ex vivo, this was ant role in atherosclerosis [89] . Circulating monocytes may directly demonstrated by showing that the production of trigger DIC, after interacting with platelets. Microvesicles TF mRNA was rapidly induced in blood cells after may accelerate this process, and the complex interaction injection of endotoxin to human volunteers [81] . In vitro, between cells, membrane fragments, soluble mediators and whole blood cells generate TF upon incubation with proteins may cause the full blown DIC syndrome. In the endotoxin or IL-1, TNFa and IL-6. In vitro, cultured endotoxin model thrombin is an important feedback achuman endothelial cells also induce TF after incubation tivator of the coagulation mechanism, because the thromwith TNFa and IL-1, but their role in DIC remains bin-specific inhibitor hirudin reduces the procoagulant unknown. Thus far, the only direct evidence for endothelial response in human volunteers [90] . The extent of catalysis involvement in TF production has been the demonstration and exhaustion of coagulation proteins and cellular eleof TF expressing circulating endothelial cells in patients ments is primarily determined by the strength of the with sickle cell disease (a possible DIC associated contriggers and the potential of the inhibitory mechanisms. dition) [82] .
Studies in primates have revealed the molecular mechanism underlying endotoxin induced activation of coagula-5 . Cross-talk between coagulation and inflammation tion [68] . After intravenous endotoxin challenge, a rapid production and liberation of proinflammatory cytokines is Coagulation activation yields proteases that not only observed. Among those, TNFa [69] and IL-6 [83] are interact with coagulation protein zymogens, but also with important for inducing fibrinolytic and procoagulant specific cell receptors to induce signaling pathways. In changes in the blood. Specifically, a rapid increase in the particular, protease interactions that affect inflammatory plasma levels of tissue plasminogen activator (tPA) and the processes may be important in the development of DIC. prothrombin fragment F112 as well as thrombin-antiFactor Xa, thrombin and the tissue factor-factor VIIa thrombin complexes (TAT) occurs. Fibrinolytic activity complex have each been shown to elicit pro-inflammatory indicated by plasmin-antiplasmin complexes is impaired activities [91, 92] . Fibrinogen / fibrin is important to the host by a subsequent rise in plasminogen activator inhibitor 1 defense mechanism, and probably has an additional role (PAI-1), and a net procoagulant state results [5] . Studies in that is not directly related to clotting per se [93] . baboons challenged with lethal amounts of E. coli (a model Thrombin has been shown to induce a variety of nonof Gram-negative septicemia) have underscored the imporcoagulant effects, some of which may influence DIC by tance of cytokines in mediating the sepsis syndrome, and affecting cytokine levels in blood. It induces production of demonstrated the prolonged proinflammatory course in monocyte chemotactic protein-1 (MCP-1) and IL-6 in which the actual formation of fibrin is particularly evident fibroblasts, epithelial cells and mononuclear cells in vitro at .24 h after E. coli challenge [84] . In fact most fibrin [94] . Endotoxin-stimulated whole blood produces signifiappears in blood, when thrombin generation is already cant IL-8, which has a procoagulant effect that is tissue declining, and evidence of endothelial cell activation factor-and thrombin-dependent [95] . Thrombin also inbecomes apparent indicated by elevated levels of soluble duces IL-6 and IL-8 production in endothelial cells. These thrombomodulin. Both in the chimpanzee endotoxin model effects of thrombin on cell activation are probably meand the E. coli model, TF is essential for inducing diated by protease-activated receptors (PARs) 1, 3 and 4 coagulation activity, and inhibition of the TF pathway [96] . PARs are cellular receptors for activated proteases abolishes clotting activation [85] . IL-6 is an important that may contribute to intracellular signaling. Several mediator of procoagulant effects, while TNFa is particustudies have indicated that the tissue factor-factor VIIa larly involved in the fibrinolytic response to endotoxin complex also activates cells by binding to PARs, and it [86] . Vice versa, inhibition of TF by TFPI reduced IL-6 in appears that PAR2 in particular is involved. Binding of the blood in the baboon model [87] , suggesting that a more catalytic tissue factor-factor VIIa complex elicits a variety extensive crosstalk between inflammatory mediators and of inflammatory effects in mononuclear cells that may coagulation exists (see further). These effects may be more influence their contribution to coagulation activity [97] . A obvious in the sepsis model, than in the endotoxin model direct indication of the relevance of these phenomena in [88] . Recent experiments in humans challenged with vivo comes from a recent study showing that infusion of endotoxin did not reveal any effect of TFPI on IL-6 nor recombinant factor VIIa into healthy human volunteers any of the other cytokines measured in blood [67] . Thus causes a rise, albeit small, in plasma levels of IL-6 and IL-8 [98] . Although the plasma concentrations of factor improve organ failure and, in some but not all cases, VIIa in this experiment were much higher than endogenous mortality [42, 87] . Lastly, clinical studies support the factor VIIa concentrations in patients with sepsis, it is notion of coagulation as an important denominator of possible that the mechanism by which VIIa causes cytokine clinical outcome. DIC has been shown to be an indepeninduction (direct or factor Xa / thrombin-mediated) is of dent predictor of mortality in patients with sepsis and physiologic importance.
severe trauma [1, 105] . Another link between inflammation and coagulation is formed by the Protein C system. Activated Protein C has anti-inflammatory effects on mononuclear cells and granulocytes, which may be distinct from its anticoagulant 7 . Coagulation and vascular complications in activity [99] . The anti-inflammatory effect of activated infectious diseases Protein C was confirmed in vivo by the demonstration of reduced TNF-a production in rats challenged with endoApart from the generalized response upon systemic toxin [52] . In addition, we have recently shown that mice inflammation as discussed above, specific infections may with a one-allele targeted deletion of the Protein C gene result in thrombohemorrhagic syndromes, hemolytic (heterozygous Protein C-deficient mice) not only develop uremic syndrome (HUS), thrombotic thrombocytopenic more severe DIC and increased fibrin deposition upon purpura (TTP) or vasculitis. Symptoms and signs may be systemic endotoxemia, but also have significantly higher dominated by bleeding, thrombosis, or both [1,79,106]. circulating levels of pro-inflammatory cytokines compared
Clinically overt infection-induced activation of coagulation with wild-type littermates [100] . These experimental data may occur in 30-50% of patients with Gram-negative are corroborated by the observations in the PROWESS sepsis [107] [108] [109] [110] . Contrary to widely held belief, this may trial that recombinant human Activated Protein C (drotappear as common in patients with Gram-positive sepsis as recogin alfa [activated] ) accelerated the decrease in levels in those with Gram-negative sepsis [111] . Activation of the of IL-6 in patients with severe sepsis [101] . For high doses coagulation system has also been documented for nonof antithrombin, similar interactions with the inflammatory bacterial pathogens, i.e. viruses [112, 113] , protozoa cascades were seen [44] . Taken together, a number of (Malaria) [114, 115] , fungi [116] and spirochetes [117] . coagulation proteases can induce pro-inflammatory mediators that have procoagulant effects, which may amplify the cascade that leads to DIC. Effects at the cellular level 7 .1. Thrombosis and bleeding will be determined by the capacity of the coagulation inhibitors to inactivate these enzymes.
Viral and bacterial infections may result in an enhanced risk for local thromboembolic disease, i.e. deep venous thrombosis or pulmonary embolism. In a thromboembolic prevention study of low-dose subcutaneous standard 6 . Relevance of the cross-talk between inflammation heparin for hospitalized patients with infectious diseases, and coagulation for organ failure morbidity due to thromboembolic disease was significantly reduced in the heparin group compared to the group There is ample evidence that inflammatory activation in receiving no prophylaxis. There was however no beneficial concert with microvascular thrombosis contributes to effect of prophylaxis on mortality due to thromboembolic multiple organ failure in patients with severe infection and complications [118] . In chronic viral diseases, such as DIC. Firstly, extensive data have been reported on post-CMV or HIV infection, the risk of thromboembolic mortem findings of patients with DIC [102, 103] . These complications is relatively low [119] [120] [121] . autopsy findings include diffuse bleeding at various sites, Viral hemorrhagic fever is complicated by DIC in the hemorraghic necrosis of tissue, microthrombi in small most severe cases [122] [123] [124] [125] [126] . DIC is not frequently blood vessels and thrombi in mid-size and larger arteries encountered in other viral infections but has been reported and veins. The demonstration of ischemia and necrosis was in cases of infection with Rotavirus [127, 128] , Varicella, invariably due to fibrin deposition in small and mid-size Rubella, Rubeola and Influenza [129] [130] [131] [132] [133] [134] [135] [136] . TTP and HUS, vessels of various organs [104] . Importantly, the presence triggered by a viral or bacterial infection [137, 138] , of these intravascular thrombi appears to be clearly and frequently lead to bleeding symptoms, but also platelet and specifically related to the clinical dysfunction of the organ.
fibrin thrombi may be generated in various organs, leading Secondly, experimental animal studies of DIC show fibrin to prominent symptoms with organ dysfunction. In specific deposition in various organs. Experimental bacteremia or infections, such as viral hemorrhagic fever, bleeding endotoxemia causes intra-and extravascular fibrin deposicomplications are prominent [122, 123] . In other viral and tion in kidneys, lungs, liver, brain and various other bacterial infections associated with TTP or HUS, bleeding organs. Amelioration of the hemostatic defect by various also is often the prominent and presenting symptom (Table  interventions in these experimental models appears to 1) [139] [140] [141] .
T able 1 shock and activation of coagulation [160, 161] [142] [143] [144] . Vasculitis is a well-documented
The change in the endothelial cell from a resting to a phenomenon in CMV infection [145, 146] , occurring preprocoagulant state may be associated with expression of dominantly in the vasculature of the gastrointestinal tract endothelial surface adhesion molecules [171] . These molewhere it causes colitis [147, 148] , the central nervous cules, i.e. ICAM, VCAM, E Selectin and von Willebrand system where it causes cerebral infarction [149, 150] , and factor (vWF), play an essential role in the binding of the skin where it results in petechiae, purpura papules, leukocytes, resulting in a local inflammatory response, localized ulcers or a diffuse maculopapular eruption [151] .
endothelial cell damage and subsequent plasma leakage HIV (human immunodeficiency virus) infection may be and shock [172, 173] . The finding of increased plasma accompanied by vasculitis syndromes, e.g. polyarteriitis concentrations of these endothelial surface adhesion molenodosa, Henoch Schonlein purpura and leukocytoclastic cules is thought to be a reflection of the level of activation vasculitis [152] [153] [154] . Hepatitis B and C infection may and perhaps damage of the endothelial cell [121] . cause polyarteritis-like vasculitis [155, 156] . Parvovirus B19 has been suggested to be associated with vasculitis-8 .2. Alterations in the protein C and S system like syndromes including Kawasaki disease, polyarteritis nodosa and Wegener's granulomatosis [157] [158] [159] .
During sepsis, the protein C / S system is downregulated, as described earlier. Some viruses have the ability to induce specific changes in the coagulation inhibitory 8 . Specific features of the pathogenesis of coagulation system. In the course of HIV infection, the protein C / S disorders in infectious disease system may be impaired as a result of an acquired protein S deficiency, the pathogenesis of which is not yet clarified Much of our knowledge on the mechanisms that play a [174, 175] . Increased plasma concentrations of the C4b-role in infection-associated activation of coagulation comes binding protein, an acute phase protein which binds protein from observations in clinical and experimental infectious S, may result in decreased levels of free protein S. disease. Essentially, and as outlined in detail in the Antiphospholipid antibodies, which may be present in HIV preceding paragraphs, several pathways appear to play a patients, might interfere with the protein C / protein S role, including tissue factor-mediated generation of thromcomplex and diminish its activity [176] . In patients with bin, impairment of physiological anticoagulant mechaDengue hemorrhagic fever, we also found decreased levels nisms, and a depression of the fibrinolytic system, due to of both protein C and protein S activity [177] . As in elevated levels of PAI-1. In addition, specific features of Dengue, HIV can affect the endothelial cell; hypothetically coagulation activation in patients with infectious disease this could lead to decreased production of protein S. may be appreciated: 8 .3. Thrombocytopenia
.1. Endothelial cell activation
Thrombocytopenia is seen in the course of many viral Endothelial cells may turn into a procoagulant state infections but is only occasionally serious enough to lead either by stimulation of cytokines in concert with circulatto hemostatic impairment and bleeding complications. It is ing blood cells, such as lymphocytes or platelets, or by assumed that thrombocytopenia is mainly immune-medirect infection (viruses) of endothelial cells. The role of diated [178] . Alternative mechanisms are decreased thromendothelial cells seems to be crucial in the development of bopoiesis, increased platelet consumption, or a combina-tion of both [179] . Direct interaction of the virus with phase II trial, a large multicenter efficacy trial was carried platelets may lead to thrombocytopenia and / or thromout [101] . This trial was prematurely stopped at the second bocytopathy [180, 181] . Endothelial injury by the virus may interim analysis because of a significant reduction in lead to increased adherence and consumption of platelets mortality in the activated protein C-treated patients. Mor- [182] . tality was 24.7% in the activated protein C group comViral infections that have been associated with thrompared with 30.8% in the placebo group (relative risk bocytopenia are Mumps, Rubella, Rubeola, Varicella, disreduction 19.4%, 95% confidence interval, 6.6-30.5). seminated Herpes simplex, CMV, infectious mononu-
The relative insufficiency of endogenous TFPI in sepsis cleosis, Hantaan virus infection, Dengue hemorrhagic and DIC may be overcome by the administration of fever, Crimean-congo hemorrhagic fever and Marburg pharmacological doses of recombinant TFPI. In a rat hemorrhagic fever [183] [184] [185] [186] [187] [188] .
model of DIC, the infusion of recombinant tissue factor pathway inhibitor (TFPI) immediately after endotoxin administration significantly inhibited the consumption of 9 . Inflammation-induced coagulation as a point of coagulation factors and platelets [191] . Furthermore, a impact for (supportive) treatment of severe infection reduced number of fibrin thrombi was formed in liver, and sepsis lungs, kidney and spleen. Similar effects were found in a rabbit model of DIC [64] . In human endotoxemia, recomBased on the assumption that defective physiological binant TFPI was shown to dose-dependently reduce thromanticoagulant mechanisms play a pivotal role in the bin generation [67] . Clinical phase II trials on the use of pathogenesis of coagulation derangement in sepsis, restora-TFPI in patients with sepsis have yielded promising results tion of these pathways may be a logical approach in the but a large multicenter phase III trial turned out to be (supportive) treatment of patients with severe sepsis. In negative, although published results are not yet available. fact, for all three anticoagulant pathways, such treatment options are available or are at an advanced stage of development.
1 0. Conclusion Restoration of the antithrombin pathway may be achieved by administration of antithrombin concentrates.
A bi-directional relationship between coagulation and The use of antithrombin concentrates in patients with DIC inflammation appears to play a pivotal role in the mechahas been studied relatively intensively. Most of these trials nisms leading to organ failure in patients with severe concern patients with sepsis and / or septic shock. All trials infection or sepsis. The endothelium plays a central role in show some beneficial effect in terms of improvement of all major pathways involved in the pathogenesis of hemoslaboratory parameters, shortening of the duration of DIC, tatic derangement during severe inflammation. Endothelial or even improvement in organ function. In the more recent cells appear to be directly involved in the initiation and clinical trials, very high doses of antithrombin concentrate regulation of thrombin generation and the inhibition of were used to attain supraphysiological plasma levels and fibrin removal. Pro-inflammatory cytokines are crucial in the beneficial results in these trials seem to be more mediating these effects on endothelial cells, which themdistinct [3, 189] . Some trials showed a modest reduction in selves may also express cytokines, thereby amplifying the mortality in antithrombin-treated patients, however, the coagulative response. The interaction between inflammaeffect never reached statistical significance. A large-scale tion and coagulation involves significant cross-talk bemulticenter randomized controlled trial to directly address tween the systems. At all levels in the activated coagulathis issue has very recently been completed [190] . Pretion system in sepsis, natural anticoagulant pathways are liminary results seem to indicate that there is no significant defective and as a consequence incapable of containing the reduction in mortality of septic patients who were treated ongoing thrombin formation. Pharmacological restoration with antithrombin concentrate. A subgroup analysis indiof these anticoagulant mechanisms may be a logical action cates that patients not receiving concomitant heparin may in the (supportive) treatment of septic patients with coaguexperience some benefit of antithrombin treatment but this lation abnormalities. Indeed, experimental and (initial) hypothesis remains to be confirmed in a prospective study.
clinical studies show beneficial results of this type of A beneficial effect of recombinant human activated treatment, not only confined to improvement of the coaguprotein C was demonstrated in two randomized controlled lation status but also on clinically relevant outcome trials. Firstly, in a dose-ranging clinical trial, 131 patients parameters such as organ function and survival. with sepsis were enrolled [101] . Included patients received activated protein C by continuous infusion at doses ranging from 12 to 30 mg / kg per h, or placebo. In these patients, a R eferences 40% reduction in the relative risk of mortality was shown, although this was not statistically significant (due to the 
